Literature DB >> 19845602

FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Matthew E Cockman1, James D Webb, Peter J Ratcliffe.   

Abstract

Studies on hypoxia-sensitive pathways have identified a series of Fe(II)-dependent dioxygenases that regulate hypoxia-inducible factor (HIF) by prolyl and asparaginyl hydroxylation. The asparaginyl hydroxylase factor inhibiting HIF (FIH) targets a conserved asparaginyl residue in the C-terminal transactivation domain of HIF-alpha. This modification suppresses HIF transcriptional activity by inhibiting co-activator recruitment. Recent work has demonstrated that FIH targets an alternative class of substrate. Proteins containing a common interaction motif known as the ankyrin repeat domain (ARD) have been shown to be efficiently hydroxylated by FIH. This review aims to summarize what is currently known regarding ARD hydroxylation, including the kinetics and determinants of FIH-mediated ARD hydroxylation, the structural and functional consequences of ARD hydroxylation, and the potential for cross-talk between ARD proteins and HIF signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845602     DOI: 10.1111/j.1749-6632.2009.05042.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  41 in total

1.  Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates.

Authors:  Sarah E Wilkins; Sarah Karttunen; Rachel J Hampton-Smith; Iain Murchland; Anne Chapman-Smith; Daniel J Peet
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.

Authors:  Han Peng; Robert B Hamanaka; Julia Katsnelson; Liang-Liang Hao; Wending Yang; Navdeep S Chandel; Robert M Lavker
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 4.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 5.  RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Authors:  Sarah E Brennan-Laun; Heather J Ezelle; Xiao-Ling Li; Bret A Hassel
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

6.  Consequences of IkappaB alpha hydroxylation by the factor inhibiting HIF (FIH).

Authors:  Ingrid L Devries; Rachel J Hampton-Smith; Melinda M Mulvihill; Vera Alverdi; Daniel J Peet; Elizabeth A Komives
Journal:  FEBS Lett       Date:  2010-11-05       Impact factor: 4.124

7.  Oxygen-dependent asparagine hydroxylation of the ubiquitin-associated (UBA) domain in Cezanne regulates ubiquitin binding.

Authors:  Julia Mader; Jessica Huber; Florian Bonn; Volker Dötsch; Vladimir V Rogov; Anja Bremm
Journal:  J Biol Chem       Date:  2020-01-14       Impact factor: 5.157

8.  FIH-1/c-kit signaling: a novel contributor to corneal epithelial glycogen metabolism.

Authors:  Han Peng; Julia Katsnelson; Wending Yang; Melissa A Brown; Robert M Lavker
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

9.  Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model.

Authors:  Bernhard Schmierer; Béla Novák; Christopher J Schofield
Journal:  BMC Syst Biol       Date:  2010-10-18

10.  Asparagine Hydroxylation is a Reversible Post-translational Modification.

Authors:  Javier Rodriguez; Cameron D Haydinger; Daniel J Peet; Lan K Nguyen; Alex von Kriegsheim
Journal:  Mol Cell Proteomics       Date:  2020-08-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.